Quarterly report [Sections 13 or 15(d)]

Condensed Consolidated Statements of Changes in Shareholders' Deficit

v3.25.3
Condensed Consolidated Statements of Changes in Shareholders' Deficit - USD ($)
Series 2 Convertible Preferred Shares
Preferred Shares
Common Shares
July 2024 Pipe Financing
Common Shares
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering
Common Shares
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering
Common Shares
Additional Paid-in Capital
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering
Additional Paid-in Capital
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering
Additional Paid-in Capital
Accumulated Other Comprehensive Loss
Accumulated Deficit
July 22, 2025 Exercise of Discounted Warrants And Pipe Offering
July 28, 2025 Exercise of Discounted Warrants And Pipe Offering
Total
Balance at the beginning at Dec. 31, 2023               $ 97,590,426 $ (371,184) $ (93,465,946)     $ 3,753,296
Balance at the beginning (in shares) at Dec. 31, 2023 1,166,667       18,885,254                
Condensed Consolidated Statements of Changes in Shareholders' Deficit                          
Share-based compensation expense               202,619         202,619
Conversion of Series 2 Convertible Preferred Shares (in shares) (1,166,667)       1,166,667                
Issuance of Common Shares from ATM Offering, net of issuance costs               190,274         190,274
Issuance of Common Shares from ATM Offering, net of issuance costs (in shares)   9,757,669     75,862                
Issuance of Common Shares from exercise of pre-funded warrants               28,039         28,039
Issuance of Common Shares from exercise of pre-funded warrants (in shares)         2,803,738                
Re-measurement of liability-classified CAD stock options               81,912         81,912
Net (loss) income                   3,017,080     3,017,080
Balance at the end at Sep. 30, 2024               98,093,270 (371,184) (90,448,866)     7,273,220
Balance at the end (in shares) at Sep. 30, 2024         32,689,190                
Balance at the beginning at Jun. 30, 2024               97,818,797 (371,184) (99,724,691)     (2,277,078)
Balance at the beginning (in shares) at Jun. 30, 2024 1,166,667       18,961,116                
Condensed Consolidated Statements of Changes in Shareholders' Deficit                          
Share-based compensation expense               121,036         121,036
Conversion of Series 2 Convertible Preferred Shares (in shares) (1,166,667)       1,166,667                
Issuance of Common Shares from ATM Offering, net of issuance costs (in shares)   9,757,669                      
Issuance of Common Shares from exercise of pre-funded warrants               28,039         28,039
Issuance of Common Shares from exercise of pre-funded warrants (in shares)         2,803,738                
Re-measurement of liability-classified CAD stock options               125,398         125,398
Net (loss) income                   9,275,825     9,275,825
Balance at the end at Sep. 30, 2024               98,093,270 (371,184) (90,448,866)     7,273,220
Balance at the end (in shares) at Sep. 30, 2024         32,689,190                
Balance at the beginning at Dec. 31, 2024               107,546,433 (371,184) (90,687,073)     16,488,176
Balance at the beginning (in shares) at Dec. 31, 2024         32,689,190                
Balance at the end at Jun. 30, 2025               108,140,611 (371,184) (108,152,006)     (382,579)
Balance at the end (in shares) at Jun. 30, 2025         32,689,190                
Balance at the beginning at Dec. 31, 2024               107,546,433 (371,184) (90,687,073)     16,488,176
Balance at the beginning (in shares) at Dec. 31, 2024         32,689,190                
Condensed Consolidated Statements of Changes in Shareholders' Deficit                          
Share-based compensation expense               654,457         654,457
Issuance of Common Shares from ATM Offering, net of issuance costs               708,468         708,468
Issuance of Common Shares from ATM Offering, net of issuance costs (in shares)         1,019,877                
Issuance of pre-funded warrants from July 2025 Registered Direct Offering, net of issuance costs               697,658         697,658
Issuance of Common Shares from exercise of pre-funded warrants               3,050         $ 3,050
Issuance of Common Shares from exercise of pre-funded warrants (in shares)         1,279,923               1,279,923
Proceeds from issuance of Common Shares and warrants from discounted warrant exercise and PIPE, net of issuance costs           $ 8,391,027 $ 11,144,468       $ 8,391,027 $ 11,144,468  
Proceeds from issuance of Common Shares and warrants from discounted warrant exercise and PIPE, net of issuance costs (in shares)     8,411,213 10,410,907                  
Re-measurement of liability-classified CAD stock options               145,110         $ 145,110
Net (loss) income                   (29,045,059)     (29,045,059)
Balance at the end at Sep. 30, 2025               129,290,671 (371,184) (119,732,132)     9,187,355
Balance at the end (in shares) at Sep. 30, 2025         53,811,110                
Balance at the beginning at Jun. 30, 2025               108,140,611 (371,184) (108,152,006)     (382,579)
Balance at the beginning (in shares) at Jun. 30, 2025         32,689,190                
Condensed Consolidated Statements of Changes in Shareholders' Deficit                          
Share-based compensation expense               197,147         197,147
Issuance of Common Shares from ATM Offering, net of issuance costs               708,468         708,468
Issuance of Common Shares from ATM Offering, net of issuance costs (in shares)         1,019,877                
Issuance of pre-funded warrants from July 2025 Registered Direct Offering, net of issuance costs               697,658         697,658
Issuance of Common Shares from exercise of pre-funded warrants               3,050         $ 3,050
Issuance of Common Shares from exercise of pre-funded warrants (in shares)         1,279,923               1,279,923
Proceeds from issuance of Common Shares and warrants from discounted warrant exercise and PIPE, net of issuance costs           $ 8,391,027 $ 11,144,468       $ 8,391,027 $ 11,144,468  
Proceeds from issuance of Common Shares and warrants from discounted warrant exercise and PIPE, net of issuance costs (in shares)     8,411,213 10,410,907                  
Re-measurement of liability-classified CAD stock options               8,242         $ 8,242
Net (loss) income                   (11,580,126)     (11,580,126)
Balance at the end at Sep. 30, 2025               $ 129,290,671 $ (371,184) $ (119,732,132)     $ 9,187,355
Balance at the end (in shares) at Sep. 30, 2025         53,811,110